Regulation of erythroid maturation by the transcriptional repressor NKAP
Regulation of erythroid maturation by the transcriptional repressor NKAP
批准号:
8911512
负责人:
Kay Lynn Medina
金额:
$31.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-01 至 2017-04-30
关键词:
AnemiaBindingBlood TransfusionCell Cycle ArrestChromatinCytosolDataDefectEmbryoErythroblastsErythrocytesErythroidErythroid CellsErythropoiesisErythropoietinErythropoietin ReceptorGenerationsGenesGeneticGlutathioneGoalsGrantHDAC3 geneHealthHematologyHemoglobinHomeostasisHumanIn VitroIronLaboratoriesLeadLifeMembrane ProteinsMitochondriaMultipotent Stem CellsMusNIH Program AnnouncementsOrganismPathway interactionsPatientsPhenocopyPhysical condensationProteinsPrussian blueRNA SplicingRefractory Anemia with Ringed SideroblastsRegulationResearchRestRoleSignal TransductionStagingStaining methodStainsStructureTFRC geneTherapeuticTherapeutic InterventionTranscription Repressor/Corepressorhuman GATA1 proteinin vivoiron metabolismnotch proteinnovelpublic health relevancereceptorresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Erythrocytes are continuously produced throughout the life of an organism. While the receptors and transcriptional regulators for the entry of multipotent progenitors into the erythroid lineage (such as GATA-1) are well characterized, the molecules that regulate the later stages of erythroid maturation are less well known. Maturation initiates only after cell cycle arrest subsequent to an erythropoietin-regulated burst of proliferation in early erythroid cells. At the erythroblast stage, iron metabolism is required for hemoglobinization. Chromatin condensation is also required for subsequent enucleation of erythroblasts prior to becoming mature red blood cells. We have found that a transcriptional repressor first defined functionally in our laboratory, NKAP, is absolutely required for erythropoiesis. Specific deletion of NKAP in the erythroid lineage using cre under the control of the erythropoietin receptor ("ErGFP-cre NKAP cKO mice") results in embryonic lethality at approximately embryonic day 11-12. At embryonic day 11.5, ErGFP- cre NKAP cKO embryos are anemic and pale. FACS analysis demonstrated that erythropoiesis does not proceed beyond the CD71+Ter119hi erythroblast stage. Therefore, NKAP is absolutely required for erythropoiesis. Our preliminary data indicated that deletion of NKAP in ST-HSC/multipotent progenitors led to decreased expression of the mitochondrial inner membrane protein ABCB7. ABCB7 transports Fe-S-glutathione clusters from the mitochondria into the cytosol, where Fe-S clusters are incorporated into proteins such as hemoglobin. In the absence of ABCB7, Fe-S clusters accumulate in the mitochondria, which can be detected using Prussian Blue staining. Consistent with decreased expression of ABCB7, conditional deletion of NKAP results in abnormal accumulation of intracellular iron. To determine whether decreased ABCB7 could be responsible for the block in erythropoiesis in the absence of NKAP, we generated an erythroid specific deletion of ABCB7 (ErGFP-cre ABCB7 cKO). Similar to ErGFP-cre NKAP cKO embryos, ErGFP-cre ABCB7 cKO embryos die at approximately embryonic e11-12, are pale and anemic, and have a block in erythropoiesis beyond the CD71+Ter119hi erythroblast stage. Thus, the phenocopy between the block in erythropoiesis in ErGFP-cre NKAP cKO embryos and ErGFP-cre ABCB7 cKO embryos indicate that ABCB7 may be the critical gene regulated by NKAP during erythropoiesis. The focus of this proposal is to understand how NKAP regulates erythropoiesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell-extrinsic emergency myelopoiesis regulated by ABCB7
-
批准号:10675321
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2023
-
负责人:Kay Lynn Medina
-
依托单位:
Regulation of the lymphoid cell fate by Hoxa9
-
批准号:10546476
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2022
-
负责人:Kay Lynn Medina
-
依托单位:
Regulation of the lymphoid cell fate by Hoxa9
-
批准号:10390559
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2022
-
负责人:Kay Lynn Medina
-
依托单位:
Maintenance and targeting of bone marrow derived allo-reactive human plasma cells
-
批准号:9164092
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2016
-
负责人:Kay Lynn Medina
-
依托单位:
Maintenance and targeting of bone marrow derived allo-reactive human plasma cells
-
批准号:9307716
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2016
-
负责人:Kay Lynn Medina
-
依托单位:
Molecular Events Initiating B Cell Fate Determination
-
批准号:7799155
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Kay Lynn Medina
-
依托单位:
Molecular Events Initiating B Cell Fate Determination
-
批准号:8040992
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Kay Lynn Medina
-
依托单位:
Molecular Events Initiating B Cell Fate Determination
-
批准号:8232043
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Kay Lynn Medina
-
依托单位:
Molecular Events Initiating B Cell Fate Determination
-
批准号:8432053
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2009
-
负责人:Kay Lynn Medina
-
依托单位:
Molecular Events Initiating B Cell Fate Determination
-
批准号:7650758
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:Kay Lynn Medina
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: